Browsing publications by Dr Dennis Lendrem

Newcastle AuthorsTitleYear
Dr Dennis Lendrem
Sheryl Mitchell
Dr Peter McMeekin
Katie Hackett
Dr Bess Price
et al.
Do the EULAR Sjögren’s syndrome outcome measures correlate with health status in primary Sjögren’s syndrome?2014
Dr Dennis Lendrem
Dr Clare Lendrem
The Development Speed Paradox: Can increasing development speed reduce R&D productivity?2014
Dr Dennis Lendrem
The Norm Chronicles: stories and numbers about danger by Michael Blastland and David Spiegelhalter2014
Dr Dennis Lendrem
The Norm Chronicles: stories and numbers about danger by Michael Blastland and David Spiegelhalter2014
Dr Karthik Balasubramaniam
Dr Girish Viswanathan
Andini Natasari
Jessica Tarn
Dr Dennis Lendrem
et al.
Assessment of blood clot formation and platelet receptor function ex vivo in patients with primary Sjögren’s syndrome2013
Professor Fai Ng
Dr Andrew Carr
Dr Ian Corbett
Professor Marco Carrozzo
Dr Dennis Lendrem
et al.
Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome.2013
Dr Dennis Lendrem
Bad pharma: how drug companies mislead doctors and harm patients by Ben Goldacre2013
Andini Natasari
Jessica Tarn
Dr Dennis Lendrem
Professor Fai Ng
Exploring the biological basis of fatigue using primary Sjögren's syndrome as a disease model2013
Dr Dennis Lendrem
Sheryl Mitchell
Dr Peter McMeekin
Dr Bridget Griffiths
Professor Fai Ng
et al.
Health-related utility values of patients with primary Sjögren's syndrome and its predictors2013
Dr Dennis Lendrem
Dr Clare Lendrem
Torching the Haystack: Modelling fast-fail strategies in drug development2013
12